SY et al. Growth Hormone and Adipocyte Function in Obesity.Horm Res 2000 Jul; 53 Suppl S1:87-97
Nam SY et al. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int J Obes Relat Metab Disord 2001 Aug;25(8):1101-7.
Nam SY, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int J Obes Relat Metab Disord. 2001 Aug;25(8):1101-7.
Napolitano LA, Schmidt D, Gotway MB, et al. Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest. 2008;118:1085-1098.
Nguyen CT, Aaronson A, Morrissey RP, Agarwal M, Willix RD, Schwarz ER. Myths and truths of growth hormone and testosterone therapy in heart failure. Expert Rev Cardiovasc Ther. 2011;9:711-720.
Niikura, T et al. Insulin-Like Growth Factor I (IGF-I) Protects Cells from Apoptosis by Alzheimer's V642I Mutant Amyloid Precursor Protein through IGF-I Receptor in an IGF-Binding Protein-Sensitive Manner The Journal of Neuroscience, March 15, 2001, 21(6):1902-1910
Nyberg F. Growth Hormone in the Brain: Characteristics of Specific Brain Targets for the Hormone and Their Functional Significance. Front Neuroendocrinol 2000 Oct; 21(4):330-348
Perrot, A. et al. Growth Hormone Treatment in Dilated Cardiomyopathy J Card. Surg 2001; 16:127-131
Pfeifer M et al. Growth Hormone (GH) Treatment Reverses Early atherosclerotic Changes in GH-Deficient Adults J Clin Endocrinol Metab 84: 453–457, 1999
Popovic V, et al Growth Horm IGF Res. 2005 Jun; 15(3):177-84. 2005 Mar 21. Hypopituitarism following traumatic brain injury
Popovic, V et al. The effectiveness of arginine + GHRH test compared with GHRH + GHRP-6 test in diagnosing growth hormone deficiency in adults. Clin Endocrinol (Oxf). 2003 Aug; 59(2):251-7
Ren J et al. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol 1999 Nov;31(11):2049-61
Rosén T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336:285-288.
Rousseau N et al. Effect of aging on growth hormone-induced insulin-like growth factor-I secretion from cultured rat chondrocytes Growth Regulation 7 (1) 1997
Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323:1-6.
Ruiz-Torres A et al. Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion. Gerontology. 2002 Nov-Dec; 48(6):401-7
Ruiz-Torres A. and Soares de Melo Kirzner M. “Ageing and Longevity Are Related to Growth Hormone/Insulun-Like Growth Factor-1 Secretion.” Gerontology 2002; 48:401-507.
Sattler F et al. Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men. JCEM 2009 94:1991-2001 March 17
Sattler F et al. Testosterone Threshold Levels and Lean Tissue Mass Targets Needed to Enhance Skeletal Muscle Strength and Function: The HORMA Trial. J Gerontol A Biol Sci Med Sci. 2010 Nov 8.
Savine R. et al Growth hormone replacement for the somatopause. Horm Res 2000; 53 Suppl 3:37-41
Savino W, Smaniotto S, Mendes-da-Cruz DA, Dardenne M. Growth hormone modulates migration of thymocytes and peripheral T cells. Ann N Y Acad Sci. 2012;1261:49-54.
Schernhammer ES et al. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Cancer. 2006 Jun; 13(2):583-592
Schneider HJ, Klotsche J, Wittchen HU, et al. Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency. Clin Endocrinol (Oxf). 2011;75:825-830.
Scirè G, Del Bianco C, Spadoni GL, Cianfarani S. Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children. J Endocrinol Invest. 2008 Feb;31(2):153-8.
Sesmilo G et al. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 2000 Jul 18; 133(2):111-22
Sesmilo G. et al. Effects of GH Administration on Homocysteine Levels in Men with GH Deficiency: A Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 4 1518-1524, 2001
Shalet SM, Brennan BM, Reddingius RE. Growth hormone therapy and malignancy. Horm Res 1997; 48 Suppl 4:29-32
Slonim AE et al. A preliminary study of growth hormone therapy for Crohn's disease. N Engl J Med 2000 Jun 1; 342(22):1633-
Soares DV, Spina LD, de Lima Oliveira Brasil RR, Lobo PM, Salles E, Coeli CM, Conceição FL, Vaisman M. Two years of growth hormone replacement therapy in a group of patients with Sheehan's syndrome. Pituitary. 2006;9(2):127-35.
Stochholm, K et al. Mortality and GH Deficiency a Nationwide Study. European Journal of Endocrinology. (2007)157 9-18
Strassberger C et al. How robust are laboratory measures of growth hormone status? Hormone Research 2005; 64:1-
Sugimoto T et al. Effect of recombinant human growth hormone in elderly osteoporotic women. Clin Endocrinol (Oxf) 1999 Dec; 51(6):715-724
Svensson J et al. Body composition and quality of life as markers of the efficacy of growth hormone replacement therapy in adults.Horm Res 2001;55 Suppl 2:55-60
Svensson J, Mattsson A, Rosén T, Wirén L, Johannsson G, Bengtsson BA, Koltowska Häggström M; Swedish KIMS National Board. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption. Growth Horm IGF Res. 2004;14:207-215.
Swerdlow A. et al. Growth Hormone Treatment of Children with Brain Tumors and Risk of Tumor Recurrence. The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 12, December 2000
Takala J et al. Increased mortality associated with GH treatment in critically ill adults. NEJM 1999; 341:785-
Thum T et al. Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-1. J Clin Endocrinol Metab. 2007 Aug 28
Tivesten, A The Growth Hormone Secretagogue Hexarelin Improves Cardiac Function in Rats after Experimental Myocardial Infarction. Endocrinology, January 2000, p. 60-66 Vol. 141, No. 1
Toogood A. et al. Growth Hormone Replacement Therapy in the Elderly with Hypothalamic-Pituitary Disease: A Dose-Finding Study. J Clin Endocrinol Metab 84: 131–136, 1999
Torella D et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 2004 Mar 5;94(4):514-24
Zoltan Ungvari and Anna
